A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2.

Methods Development
Medicinal Chemistry

Abstract

Lipoxygenase (LOX) enzymes catalyze the hydroperoxidation of arachidonic acid and other polyunsaturated fatty acids to hydroxyeicosatetraenoic acids with varying positional specificity to yield important biological signaling molecules. Human epithelial 15-lipoxygenase-2 (15-LOX-2) is a highly specific LOX isozyme that is expressed in epithelial tissue and whose activity has been correlated with suppression of tumor growth in prostate and other epithelial derived cancers. Despite the potential utility of an inhibitor to probe the specific role of 15-LOX-2 in tumor progression, no such potent/specific 15-LOX-2 inhibitors have been reported to date. This study employs high throughput screening to identify two novel, specific 15-LOX-2 inhibitors. MLS000545091 is a mixed-type inhibitor of 15-LOX-2 with a Ki of 0.9+/-0.4 µM and has a 20-fold selectivity over 5-LOX, 12-LOX, 15-LOX-1, COX-1, and COX-2. MLS000536924 is a competitive inhibitor with a Ki of 2.5+/-0.5 µM and also possesses 20-fold selectivity toward 15-LOX-2 over the other oxygenases, listed above. Finally, neither compound possesses reductive activity towards the active-site ferrous ion.

Authors

Jameson, J Brian; Kantz, Auric; Schultz, Lena; Kalyanaraman, Chakrapani; Jacobson, Matthew P; Maloney, David J; Jadhav, Ajit; Simeonov, Anton; Holman, Theodore R;

Keywords

  • Arachidonate 15-Lipoxygenase/ chemistry
  • Arachidonate 15-Lipoxygenase/ metabolism
  • Drug Evaluation, Preclinical
  • Epithelium/ enzymology
  • High-Throughput Screening Assays
  • Humans
  • Kinetics
  • Lipoxygenase Inhibitors/ chemistry
  • Lipoxygenase Inhibitors/ metabolism
  • Lipoxygenase Inhibitors/ pharmacology
  • Molecular Docking Simulation
  • Protein Conformation

External Links